Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Imepitoin
Другие языки:

Imepitoin

Подписчиков: 0, рейтинг: 0
Imepitoin
Imepitoin.svg
Clinical data
Trade names Pexion
Other names AWD 131-138; ELB-138
Routes of
administration
Oral
ATCvet code
Identifiers
  • 3-(4-Chlorophenyl)-5-morpholin-4-yl-4H-imidazol-2-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.220.751
Chemical and physical data
Formula C13H14ClN3O2
Molar mass 279.72 g·mol−1
3D model (JSmol)
  • C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl
  • InChI=1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2
  • Key:IQHYCZKIFIHTAI-UHFFFAOYSA-N

Imepitoin (INN), sold under the brand name Pexion, is an anticonvulsant which is used in veterinary medicine in Europe to treat epilepsy in dogs. It was recently approved in the United States. The drug also has anxiolytic effects. It was originally developed to treat epilepsy in humans, but clinical trials were terminated upon findings of unfavorable metabolic differences in smokers and non-smokers.

Imepitoin acts as a low-affinity (4,350–5,140 nM; relative to Ki = 6.8 nM for diazepam and Ki = 1.7 nM for clonazepam) partial agonist of the benzodiazepine site of the GABAA receptor (up to 12–21% of the maximal potentiation of diazepam, a full agonist of this site). It is the first partial agonist to be approved for the treatment of epilepsy. The drug also dose-dependently blocks voltage-gated calcium channels. It is not a benzodiazepine; instead, it is an imidazolone, and bears some structural similarities to hydantoin anticonvulsants like ethotoin and phenytoin.

See also



Новое сообщение